AZ's Lynparza receives Japanese approval

Japan’s Ministry of Health, Labour and Welfare (MHLW) approved Lynparza olaparib from AstraZeneca plc (LSE:AZN; NYSE:AZN) and

Read the full 170 word article

User Sign In